Indeed, we further found that 3-TYP treatment reduced SLC7A11 expression in tumor tissues, which was the reason for the decreased GSH/GSSG ratio in GBM tumors in xenograft mice (Fig. 5E, F). This evidence concerns the gene SLC7A11 and glioblastoma.